- Home
- ATUS vs NKTR Comparison
ATUS vs NKTR Comparison
Compare ATUS & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATUS
- NKTR
- Stock Information
- Founded
- ATUS 2015
- NKTR 1990
- Country
- ATUS United States
- NKTR United States
- Employees
- ATUS N/A
- NKTR N/A
- Industry
- ATUS Cable & Other Pay Television Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- ATUS Telecommunications
- NKTR Health Care
- Exchange
- ATUS Nasdaq
- NKTR Nasdaq
- Market Cap
- ATUS 1.1B
- NKTR 1.2B
- IPO Year
- ATUS 2017
- NKTR 1994
- Fundamental
- Price
- ATUS $2.70
- NKTR $56.56
- Analyst Decision
- ATUS Hold
- NKTR Strong Buy
- Analyst Count
- ATUS 6
- NKTR 6
- Target Price
- ATUS $2.88
- NKTR $91.67
- AVG Volume (30 Days)
- ATUS 4.3M
- NKTR 1.2M
- Earning Date
- ATUS 11-06-2025
- NKTR 11-06-2025
- Dividend Yield
- ATUS N/A
- NKTR N/A
- EPS Growth
- ATUS N/A
- NKTR N/A
- EPS
- ATUS N/A
- NKTR N/A
- Revenue
- ATUS $8,762,212,000.00
- NKTR $74,934,000.00
- Revenue This Year
- ATUS N/A
- NKTR N/A
- Revenue Next Year
- ATUS N/A
- NKTR N/A
- P/E Ratio
- ATUS N/A
- NKTR N/A
- Revenue Growth
- ATUS N/A
- NKTR N/A
- 52 Week Low
- ATUS $1.95
- NKTR $6.48
- 52 Week High
- ATUS $3.20
- NKTR $62.95
- Technical
- Relative Strength Index (RSI)
- ATUS 56.69
- NKTR 64.44
- Support Level
- ATUS $2.35
- NKTR $57.47
- Resistance Level
- ATUS $2.63
- NKTR $62.82
- Average True Range (ATR)
- ATUS 0.13
- NKTR 3.34
- MACD
- ATUS 0.01
- NKTR -0.96
- Stochastic Oscillator
- ATUS 56.25
- NKTR 36.74
About ATUS Altice USA Inc.
Altice Europe acquired privately held US cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and businesses in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.